Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-01
2008-01-01
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000
Reexamination Certificate
active
07314867
ABSTRACT:
The present invention provides a pharmaceutical composition comprising a peptide selected from the group consisting of D-Pro D-Tyr D-Val D-Val, D-Pro D-Tyr D-Val, and D-Leu D-Thr D-Val as an active component. The composition of the present invention has great efficacy in lowering serum triglyceride levels.
REFERENCES:
patent: 4473555 (1984-09-01), Nestor et al.
patent: 5218089 (1993-06-01), Mariotti et al.
patent: 5451658 (1995-09-01), Seelig
patent: 5723443 (1998-03-01), Kagawa et al.
patent: 5756467 (1998-05-01), Kagawa et al.
patent: 5831003 (1998-11-01), Baumbach et al.
patent: 5958885 (1999-09-01), Kagawa et al.
patent: 6046168 (2000-04-01), Kagawa et al.
patent: 2005/0049193 (2005-03-01), Grasso et al.
patent: 0 253 190 (1988-01-01), None
patent: 0 253 190 (1988-01-01), None
patent: 0 838 473 (2002-10-01), None
Abstract of JP 11-263733 (Sep. 1999).
Abstract of WO 97/00890 (Jan. 1997).
Abstract of WO 89/06970 (Aug. 1989).
Josef R. Patsch, et al., Relation of Triglyceride Metabolism and Coronary Artery Disease, Arteriosclerosis and Thrombosis, 199, 12:1336-1345.
Michael Chorev, et al., A Dozen Years of Retro-Inverso Peptidomimetics, Acc, Chem. Res, 1993, 26, 266-274.
Michael Choev, et al. Recent Developments In Retro Peptides And Proteins—An Ongoing Topochemical Exploration, Tibtech, Oct. 1995, vol. 13, pp. 438-445.
Matthew David Fletcher, et al., Partially Modified Retro-Inverso Peptides: Development, Synthesis, and Conformational Behavior, Chem. Rev. 1998, 98, 763-795.
Melissa A. Austin, Plasma Triglyceride As A Risk Factor For Coronary Heart Disease, The Epidemiologic Evidence and Beyond, American Journal of Epidemiology, 1989, vol. 129, No. 2, pp. 249-259.
S. Muller, The Potential of Retro-Inverso Peptides as Synthetic Vaccines, Ashley Publications Ltd., 1998, ISSN 1354-3784, pp. 1429-1439.
F. Nargi, Protection of Swine from Foot-and-Mouth Disease with One Doe of an All-D Retro Peptide, Vaccine 17 (1999) 288-2893.
Frommer & Lawrence & Haug LLP
Lukton David
Santucci Ronald R.
LandOfFree
Pharmaceutical composition comprising a retro-iverso isomer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising a retro-iverso isomer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a retro-iverso isomer... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2747071